Emerging Computational Technologies in Breast Cancer Research

Abstract

Breast cancer remains one of the most extensively investigated malignancies worldwide and continues to be a leading cause of cancer-related morbidity and mortality despite substantial advances in molecular diagnostics, targeted therapeutics, and precision medicine. Rapid developments in computational technologies have transformed breast cancer research by enabling comprehensive analysis of complex biomedical datasets generated through medical imaging, digital pathology, genomic sequencing, transcriptomics, proteomics, metabolomics, single-cell sequencing, liquid biopsy, wearable technologies, and electronic health records. Artificial intelligence (AI), machine learning, deep learning, natural language processing, graph neural networks, digital twins, quantum computing, multimodal learning, cloud computing, and foundation models are increasingly supporting biomarker discovery, molecular characterization, disease prediction, treatment optimization, drug discovery, and clinical decision support. These computational approaches facilitate integration of heterogeneous biological information into predictive models that improve personalized breast cancer management while accelerating translational research. Emerging technologies such as explainable artificial intelligence, federated learning, generative AI, spatial transcriptomics, digital pathology, and computational systems biology are expected to further revolutionize precision breast oncology. Despite remarkable progress, challenges remain regarding data standardization, interoperability, computational complexity, cybersecurity, algorithmic bias, regulatory validation, and ethical implementation. This review explores the rapidly evolving landscape of computational technologies in breast cancer research, highlighting current innovations, clinical applications, implementation challenges, and future directions for computational precision oncology.